Share Email Print
cover

Proceedings Paper

Arch Venture Partners' investment considerations for CBRNE products and opportunities
Author(s): K. Crandell; S. Lazarus; P. J. Gardner
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

ARCH is interested in building leading, highly-valued companies from leading research. Toward that end we value innovations created by the leading researchers in the world, many of which are funded to solve critical scientific challenges including those in the instrumentation and CBRNE area. The most important CBRNE innovations we have seen at ARCH are breakthroughs involving significant unaddressed technology risk and have the potential for broad proprietary intellectual property as a result. The model ARCH has evolved in instrumentation is to look for a breakthrough innovation, with strong intellectual property and continue to strengthen the patent estate through the life of the company. ARCH looks to build companies around leading interdisciplinary scientific and engineering teams, and we favor platform technology that can be applied to multiple market applications both commercial and government. As part of a strategy to build a great company, addressing important CBRNE challenges can help a company strengthen its technical team and its IP estate. This supports a focus on early low volume markets on the way toward addressing a fuller portfolio of applications. Experienced Venture Capitalists can help this process by identifying important executive talent, partners and applications, offering financial syndication strength, and helping shape the company's strategy to maximize the ultimate value realized.

Paper Details

Date Published: 1 May 2008
PDF: 4 pages
Proc. SPIE 6954, Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) Sensing IX, 69540U (1 May 2008); doi: 10.1117/12.783466
Show Author Affiliations
K. Crandell, ARCH Venture Partners (United States)
S. Lazarus, ARCH Venture Partners (United States)
P. J. Gardner, Western Carolina Univ. (United States)


Published in SPIE Proceedings Vol. 6954:
Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) Sensing IX
Augustus Way Fountain; Patrick J. Gardner, Editor(s)

© SPIE. Terms of Use
Back to Top